Open-Label Risperidone Treatment of 6 Children and Adolescents with Autism

[1]  R. Nicolson,et al.  An open trial of risperidone in young autistic children. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[2]  C. McDougle,et al.  Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  H. Demb.  Risperidone in young children with pervasive developmental disorders and other developmental disabilities. , 1996, Journal of child and adolescent psychopharmacology.

[4]  A. Labelle,et al.  Risperidone in the Treatment of Pervasive Developmental Disorder , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[5]  B. H. Herman,et al.  A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism , 1990, Biological Psychiatry.

[6]  C. Barthélémy,et al.  The behavioral summarized evaluation: Validity and reliability of a scale for the assessment of autistic behaviors , 1990, Journal of autism and developmental disorders.